UK Companies House feature
ORGANON PHARMA (UK) LIMITED
Profile
- Company number
- 00820771
- Status
- Active
- Incorporation
- 1964-09-25
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company's parent (Organon & Co.) and Company's financial position allows the Company to maintain liquidity and access capital markets through their ultimate parent company, as needed. After reviewing the company's forecasts and projections, the company is still in an overdraft position and therefore needs to take advantage of the group cash pooling arrangements. The directors have obtained a Letter of Support from its ultimate parent company Organon & Co. confirming support to enable the company to meet its liabilities when they fall due for a period of at least 12 months from the date of approval of the financial statements. The company therefore continues to adopt the going concern basis in preparing its financial statements.”
Significant events
- “The company generated a loss for the financial year of £2,023,000 due to an exceptional tax payment made in 2024 of £8,225,392, related to a tax settlement with HMRC from a historic transfer pricing inquiry.”
- “The new product Emgality, a migraine treatment, was launched in 2024, contributing to a 25% increase in turnover for the commercial portfolio.”
- “A planned medical device is being launched in 2025 for the Women's health therapy area.”
- “In January 2025, Organon Pharma UK received a refund of £2,546,000 from the Department of Health related to the VPAS 2023 scheme, treated as a post balance sheet adjusting item.”
- “Total GHG emissions and intensity ratio increased by 137% compared to the previous year, driven by a large increase in gas usage and a shift from biomass electricity to national grid electricity.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
6 active · 36 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| PARSONS, John Albert | Secretary | 2021-05-28 | — | — |
| BARR, Nicola | Director | 2025-09-01 | Aug 1976 | British |
| BITZER, Anne | Director | 2025-09-01 | Jan 1981 | French |
| LASKOWSKI, Josef Ralph | Director | 2024-03-01 | Oct 1980 | British |
| PAULOS FERREIRA ALVES DA SILVA, Sofia Raquel | Director | 2025-09-01 | Sep 1977 | Portuguese |
| WHALE, Michael | Director | 2024-03-01 | Jan 1972 | British |
Show 36 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DALBY, Marc Charles | Secretary | 1992-08-15 | 2007-01-19 |
| DAVIES, Amy | Secretary | 2020-11-23 | 2021-06-01 |
| FADDEN, Kathleen | Secretary | — | 1992-08-15 |
| MCARDLE, Kevin Edward | Secretary | 2007-04-04 | 2011-06-28 |
| ROBINSKI, Richard | Secretary | 2011-06-28 | 2020-11-23 |
| ANSTICE, David Westbrook | Director | 1993-05-21 | 1994-10-04 |
| ARMITAGE, Robert | Director | 2003-09-19 | 2012-03-23 |
| ARMITAGE, Robert John | Director | 1993-12-10 | 2001-01-01 |
| BELL, Graeme | Director | 2009-06-23 | 2009-11-05 |
| BEYNON, Colin Bowen | Director | — | 1995-10-31 |
| BOUSFIELD, Keith | Director | 2012-03-23 | 2014-12-31 |
| BREWER, Melvyn Frederick | Director | 1995-03-22 | 1997-07-31 |
| CLIFFE, Christopher Frederick | Director | — | 1993-03-31 |
| DAHL, Torben | Director | 2021-05-28 | 2024-02-29 |
| DALBY, Marc Charles | Director | 1994-03-31 | 2007-01-19 |
| HOUSON, Louise Jane | Director | 2016-09-06 | 2019-10-01 |
| HUSSAIN, Simon Khalid | Director | 2021-05-28 | 2024-02-29 |
| IVERSEN, Leslie Lars, Professor | Director | — | 1994-03-30 |
| JACKSON, James Russell | Director | 2001-01-01 | 2003-05-31 |
| KHANNA, Deepak Kumar | Director | 2009-11-04 | 2014-06-30 |
| LANE, Richard John | Director | — | 1993-05-21 |
| LAWTON, Vincent Michael | Director | — | 2006-06-28 |
| LEONARD, Melissa | Director | 2013-12-11 | 2016-10-15 |
| LINDSEY, Sandy | Director | 2024-03-01 | 2025-05-30 |
| LITCHFIELD, Caroline Ann | Director | 2003-06-25 | 2009-06-23 |
| MCDOWELL, Mark Andrew Charles | Director | 2009-11-04 | 2013-12-31 |
| NALLY, Michael Thomas | Director | 2014-06-30 | 2016-09-30 |
| NICHOLSON, Simon | Director | 2014-12-31 | 2024-02-15 |
| PEACOCK, David | Director | 2019-10-01 | 2021-05-28 |
| POLZ, Gertraud | Director | 2016-09-06 | 2017-06-23 |
| ROUND, Christopher | Director | 2006-07-13 | 2009-11-06 |
| ROUND, Christopher | Director | 1996-06-03 | 2003-07-31 |
| TEMUCIN, Ebru Can | Director | 2017-06-23 | 2021-05-28 |
| VANDENBERK, Isabel | Director | 2024-03-01 | 2025-07-31 |
| WAKELIN, James | Director | — | 1994-04-21 |
| WHITE, Katherine Elizabeth | Director | 2014-12-31 | 2016-03-18 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Organon & Co. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-06-02 | Active |
| Merck & Co., Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-03-22 | Ceased 2021-06-02 |
| Merck Sharp & Dohme (Uk) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2021-03-22 |
Filing timeline
Last 20 of 252 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-10-03 | AA | accounts | accounts with accounts type full |
| 2025-09-25 | AP01 | officers | appoint person director company with name date |
| 2025-09-10 | AP01 | officers | appoint person director company with name date |
| 2025-09-10 | AP01 | officers | appoint person director company with name date |
| 2025-08-19 | TM01 | officers | termination director company with name termination date |
| 2025-07-10 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-06-26 | TM01 | officers | termination director company with name termination date |
| 2024-12-05 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2024-09-30 | AA | accounts | accounts with accounts type full |
| 2024-07-10 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-06-21 | AD01 | address | change registered office address company with date old address new address |
| 2024-06-06 | AD01 | address | change registered office address company with date old address new address |
| 2024-03-25 | TM01 | officers | termination director company with name termination date |
| 2024-03-25 | AP01 | officers | appoint person director company with name date |
| 2024-03-22 | TM01 | officers | termination director company with name termination date |
| 2024-03-22 | TM01 | officers | termination director company with name termination date |
| 2024-03-22 | AP01 | officers | appoint person director company with name date |
| 2024-03-22 | AP01 | officers | appoint person director company with name date |
| 2024-03-21 | AP01 | officers | appoint person director company with name date |
| 2023-10-05 | AA | accounts | accounts with accounts type full |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.